Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-010908
Filing Date
2025-03-06
Accepted
2025-03-06 16:02:41
Documents
99
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vyne-20241231.htm   iXBRL 10-K 1997452
2 EX-10.19 amendmenttolicenseagreemen.htm EX-10.19 35962
3 EX-19 vyne-insidertradingandsect.htm EX-19 96962
4 EX-21.1 exhibit211-subsidiaries.htm EX-21.1 1659
5 EX-23.1 exhibit231consentus12312024.htm EX-23.1 2225
6 EX-31.1 vyne-20241231xexx311.htm EX-31.1 10734
7 EX-31.2 vyne-20241231xexx312.htm EX-31.2 10728
8 EX-32.1 vyne-20241231xexx321.htm EX-32.1 6883
9 EX-32.2 vyne-20241231xexx322.htm EX-32.2 6850
15 image_0.jpg GRAPHIC 125792
16 vyne-20241231_g1.jpg GRAPHIC 264882
  Complete submission text file 0001628280-25-010908.txt   9720907

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20241231.xsd EX-101.SCH 54335
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20241231_cal.xml EX-101.CAL 81679
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20241231_def.xml EX-101.DEF 287335
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20241231_lab.xml EX-101.LAB 726420
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20241231_pre.xml EX-101.PRE 524484
102 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20241231_htm.xml XML 940383
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38356 | Film No.: 25715123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)